Pnc Financial Services Group, Inc. Oncorus, Inc. Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$5.03 - $11.63 $57,845 - $133,745	-11,500 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$13.3 - $17.3 $129,595 - $168,571	-9,744 Reduced 45.87%	11,500 $158,000
Q1 2021 May 07, 2021	BUY	$11.89 - $35.55 $136,735 - $408,824	11,500 Added 118.02%	21,244 $295,000
Q4 2020 Feb 12, 2021	BUY	$15.0 - $35.15 $146,160 - $342,501	9,744 New	9,744 $315,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.